OmniAb, Inc. (OABI) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
OmniAb (OABI) Q1 2026: Milestone Revenue Surges 243% on Pipeline Progress, Guidance Raised
May 08, 2026
-
OmniAb (OABI) Q4 2025: Active Programs Up 12%, Innovation Engines Expand Addressable Market
March 05, 2026
-
OmniAb (OABI) Q3 2025: Program Count Hits 399, OmniUltra Launch Expands Peptide Market Access
November 05, 2025
-
OmniAb (OABI) Q2 2025: Exploration Launch Drives 22% Growth in Post-Discovery Pipeline
August 06, 2025
-
OmniAb (OABI) Q1 2025: Exploration Launch Expands Revenue Streams as Post-Discovery Assets Rise 39%
July 05, 2025